Marshall Wace, LLP Rocket Pharmaceuticals, Inc. Transaction History

Marshall Wace, LLP

$74.4 Billion
Q1 2025

A detailed history of Marshall Wace, LLP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 438,617 shares of RCKT stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

438,617

Previous 456,762 3.97%

Holding current value

$1.09 Million

Previous $5.74 Million 49.05%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$6.67 - $12.72 $121,027 - $230,804	-18,145 Reduced 3.97%	438,617 $2.93 Million
Q4 2024 Feb 13, 2025	BUY	$11.35 - $18.82 $5.07 Million - $8.41 Million	446,662 Added 4422.4%	456,762 $5.74 Million
Q3 2024 Nov 14, 2024	SELL	$17.6 - $25.88 $166,900 - $245,420	-9,483 Reduced 48.42%	10,100 $186,000
Q2 2024 Aug 14, 2024	BUY	$20.66 - $26.72 $404,584 - $523,257	19,583 New	19,583 $421,000
Q4 2022 Feb 14, 2023	SELL	$15.5 - $22.76 $1.37 Million - $2.01 Million	-88,356 Reduced 86.75%	13,500 $264,000
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $1.09 Million - $1.62 Million	88,056 Added 638.09%	101,856 $1.63 Million
Q2 2022 Aug 15, 2022	BUY	$7.96 - $16.64 $109,848 - $229,632	13,800 New	13,800 $190,000
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $1.26 Million - $2.26 Million	-95,569 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $2.06 Million - $3.44 Million	95,569 New	95,569 $2.09 Million
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $1.53 Million - $2.33 Million	-35,390 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $824,587 - $2.11 Million	35,390 New	35,390 $1.94 Million
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $37,645 - $97,351	-3,877 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $28,483 - $62,343	2,573 Added 197.32%	3,877 $88,000
Q3 2019 Nov 14, 2019	SELL	$10.85 - $14.78 $1.42 Million - $1.93 Million	-130,444 Reduced 99.01%	1,304 $15,000
Q2 2019 Aug 14, 2019	SELL	$15.0 - $19.81 $213,660 - $282,173	-14,244 Reduced 9.76%	131,748 $1.98 Million
Q1 2019 May 14, 2019	BUY	$13.45 - $19.01 $1.96 Million - $2.78 Million	145,992 New	145,992 $2.56 Million

Others Institutions Holding RCKT

# of Institutions

258

Shares Held

108M

Call Options Held

555K

Put Options Held

177K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $188M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Rocket Pharmaceuticals, Inc. Transaction History